Form 8-K - Current report:
SEC Accession No. 0001104659-25-082783
Filing Date
2025-08-26
Accepted
2025-08-26 07:16:20
Documents
64
Period of Report
2025-08-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2524197d1_8k.htm   iXBRL 8-K 26694
2 EXHIBIT 99.1 tm2524197d1_ex99-1.htm EX-99.1 22121
3 EXHIBIT 99.2 tm2524197d1_ex99-2.htm EX-99.2 25139
4 EXHIBIT 99.3 tm2524197d1_ex99-3.htm EX-99.3 34019
8 GRAPHIC tm2524197d1_ex99-1img001.jpg GRAPHIC 4607
9 GRAPHIC tm2524197d1_ex99-2img001.jpg GRAPHIC 118165
10 GRAPHIC tm2524197d1_ex99-2img002.jpg GRAPHIC 368643
11 GRAPHIC tm2524197d1_ex99-2img003.jpg GRAPHIC 227476
12 GRAPHIC tm2524197d1_ex99-2img004.jpg GRAPHIC 108893
13 GRAPHIC tm2524197d1_ex99-2img005.jpg GRAPHIC 205847
14 GRAPHIC tm2524197d1_ex99-2img006.jpg GRAPHIC 148824
15 GRAPHIC tm2524197d1_ex99-2img007.jpg GRAPHIC 124541
16 GRAPHIC tm2524197d1_ex99-2img008.jpg GRAPHIC 170746
17 GRAPHIC tm2524197d1_ex99-2img009.jpg GRAPHIC 149229
18 GRAPHIC tm2524197d1_ex99-2img010.jpg GRAPHIC 129388
19 GRAPHIC tm2524197d1_ex99-2img011.jpg GRAPHIC 211670
20 GRAPHIC tm2524197d1_ex99-2img012.jpg GRAPHIC 156420
21 GRAPHIC tm2524197d1_ex99-2img013.jpg GRAPHIC 188824
22 GRAPHIC tm2524197d1_ex99-2img014.jpg GRAPHIC 153957
23 GRAPHIC tm2524197d1_ex99-2img015.jpg GRAPHIC 113408
24 GRAPHIC tm2524197d1_ex99-2img016.jpg GRAPHIC 174016
25 GRAPHIC tm2524197d1_ex99-2img017.jpg GRAPHIC 116031
26 GRAPHIC tm2524197d1_ex99-2img018.jpg GRAPHIC 208346
27 GRAPHIC tm2524197d1_ex99-2img019.jpg GRAPHIC 167904
28 GRAPHIC tm2524197d1_ex99-2img020.jpg GRAPHIC 78578
29 GRAPHIC tm2524197d1_ex99-3img001.jpg GRAPHIC 116076
30 GRAPHIC tm2524197d1_ex99-3img002.jpg GRAPHIC 352478
31 GRAPHIC tm2524197d1_ex99-3img003.jpg GRAPHIC 223929
32 GRAPHIC tm2524197d1_ex99-3img004.jpg GRAPHIC 102995
33 GRAPHIC tm2524197d1_ex99-3img005.jpg GRAPHIC 196202
34 GRAPHIC tm2524197d1_ex99-3img006.jpg GRAPHIC 138733
35 GRAPHIC tm2524197d1_ex99-3img007.jpg GRAPHIC 115302
36 GRAPHIC tm2524197d1_ex99-3img008.jpg GRAPHIC 159657
37 GRAPHIC tm2524197d1_ex99-3img009.jpg GRAPHIC 141634
38 GRAPHIC tm2524197d1_ex99-3img010.jpg GRAPHIC 125019
39 GRAPHIC tm2524197d1_ex99-3img011.jpg GRAPHIC 194077
40 GRAPHIC tm2524197d1_ex99-3img012.jpg GRAPHIC 148632
41 GRAPHIC tm2524197d1_ex99-3img013.jpg GRAPHIC 178203
42 GRAPHIC tm2524197d1_ex99-3img014.jpg GRAPHIC 144291
43 GRAPHIC tm2524197d1_ex99-3img015.jpg GRAPHIC 105206
44 GRAPHIC tm2524197d1_ex99-3img016.jpg GRAPHIC 125247
45 GRAPHIC tm2524197d1_ex99-3img017.jpg GRAPHIC 138451
46 GRAPHIC tm2524197d1_ex99-3img018.jpg GRAPHIC 149274
47 GRAPHIC tm2524197d1_ex99-3img019.jpg GRAPHIC 171915
48 GRAPHIC tm2524197d1_ex99-3img020.jpg GRAPHIC 159919
49 GRAPHIC tm2524197d1_ex99-3img021.jpg GRAPHIC 123450
50 GRAPHIC tm2524197d1_ex99-3img022.jpg GRAPHIC 143721
51 GRAPHIC tm2524197d1_ex99-3img023.jpg GRAPHIC 122801
52 GRAPHIC tm2524197d1_ex99-3img024.jpg GRAPHIC 122262
53 GRAPHIC tm2524197d1_ex99-3img025.jpg GRAPHIC 142666
54 GRAPHIC tm2524197d1_ex99-3img026.jpg GRAPHIC 89822
55 GRAPHIC tm2524197d1_ex99-3img027.jpg GRAPHIC 125038
56 GRAPHIC tm2524197d1_ex99-3img028.jpg GRAPHIC 77128
  Complete submission text file 0001104659-25-082783.txt   10580780

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mrkr-20250826.xsd EX-101.SCH 3017
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrkr-20250826_lab.xml EX-101.LAB 34239
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrkr-20250826_pre.xml EX-101.PRE 22360
66 EXTRACTED XBRL INSTANCE DOCUMENT tm2524197d1_8k_htm.xml XML 3811
Mailing Address 2450 HOLCOMBE BLVD TMC PARTNERS OFFICE 1.311 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD TMC PARTNERS OFFICE 1.311 HOUSTON TX 77021 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37939 | Film No.: 251252609
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)